Valuation: Dermapharm Holding SE

Market Cap 1.98B 2.3B 1.87B 1.7B 3.19B 220B 3.24B 21.9B 8.58B 110B 8.62B 8.44B 367B P/E 2026 *
16.1x
P/E 2027 * 13.7x
Enterprise Value 2.68B 3.1B 2.52B 2.29B 4.31B 297B 4.37B 29.58B 11.59B 149B 11.65B 11.4B 495B EV / Sales 2026 *
2.22x
EV / Sales 2027 * 2.09x
Free-Float
10.7%
Yield 2026 *
2.54%
Yield 2027 * 2.81%
1 day+0.37%
1 week+0.12%
Current month-2.20%
1 month-4.98%
3 months-17.32%
6 months+5.94%
Current year+1.91%
1 week 38.95
Extreme 38.95
40.5
1 month 38.95
Extreme 38.95
43.5
Current year 34.3
Extreme 34.3
51.9
1 year 31.7
Extreme 31.7
51.9
3 years 30.15
Extreme 30.15
51.9
5 years 30.15
Extreme 30.15
91.95
10 years 21.58
Extreme 21.575
91.95
Manager TitleAgeSince
Chief Executive Officer 64 01/08/2017
Director of Finance/CFO - 01/11/2022
Investor Relations Contact - 01/12/2018
Director TitleAgeSince
Chairman 70 01/08/2017
Director/Board Member 66 01/08/2017
Director/Board Member 77 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
1/7/26 A Buy 150 0.0003%
1/7/26 A Buy 150 0.0003%
1/7/26 A Buy 2,050 0.0038%
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%+0.12%+18.64%-15.22% 2.3B
+5.12%+5.30%+82.73%+133.61% 1,093B
+1.62%+5.49%+54.77%+64.44% 653B
+2.56%+6.17%+28.10%+75.89% 458B
+2.00%+0.25%+40.81%+44.08% 355B
+1.40%+2.11%+25.69%+40.91% 294B
+2.73%+3.26%+2.56%+13.21% 248B
+3.59%+5.32%+48.30%+68.12% 230B
+1.86%+0.38%-13.62%-52.32% 203B
+3.70%+9.10%+25.64%+95.19% 178B
Average +2.52%+1.16%+31.36%+46.79% 371.28B
Weighted average by Cap. +3.14%+1.45%+47.03%+74.25%

Financials

2026 *2027 *
Net sales 1.21B 1.4B 1.14B 1.03B 1.94B 134B 1.97B 13.34B 5.23B 67.05B 5.25B 5.14B 223B 1.25B 1.45B 1.18B 1.07B 2.02B 139B 2.05B 13.84B 5.43B 69.6B 5.45B 5.33B 232B
Net income 134M 155M 126M 114M 215M 14.82B 218M 1.47B 578M 7.41B 581M 568M 24.68B 155M 180M 146M 133M 250M 17.21B 253M 1.71B 671M 8.61B 674M 660M 28.67B
Net Debt 696M 806M 655M 595M 1.12B 77.19B 1.14B 7.68B 3.01B 38.61B 3.02B 2.96B 129B 636M 736M 598M 543M 1.02B 70.5B 1.04B 7.01B 2.75B 35.26B 2.76B 2.7B 117B
Logo Dermapharm Holding SE
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Employees
3,503
Date Price Change Volume
19/08/26 40.10 +0.12% 11,223
18/08/26 €40.05 +0.50% 44,759
17/08/26 €39.85 +0.63% 12,608
14/08/26 €39.60 -0.88% 25,502
13/08/26 €39.95 -0.25% 19,957
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
40.05EUR
Average target price
50.38EUR
Spread / Average Target
+25.78%

Quarterly revenue - Rate of surprise